Niosomes Encapsulated in Biohydrogels for Tunable Delivery of Phytoalexin Resveratrol
Overview
Affiliations
A series of biohydrogels based on mixtures of kappa-carrageenan (κ-carrageenan, κ-C) and gelatin were evaluated as potential soft delivery vehicles for the encapsulation and subsequent release of non-ionic surfactant vesicles (niosomes) loaded with resveratrol (RSV). The niosomes were prepared using a mixture of amphiphilic lipids Tween 80 and Span 80 in water. The results showed that RSV-niosomes did not significantly affect the hydrogelation properties of the biopolymer mixture. Moreover, drug release experiments from biohydrogels containing RSV-niosomes were successfully carried out under simulated gastrointestinal conditions. The RSV-niosomal liberation profiles from hydrogels were fitted using first order kinetics, Higuchi, Korsmeyer-Peppas and Weibull drug release models, showing the prevalence of diffusion mechanisms in each case. In addition, the RSV release was easily tuned by adjusting the total concentration of κ-C : gelatin. Interestingly, the niosomal-hydrogel system was also found to prevent the -to- photoisomerization of RSV.
Resveratrol-A Promising Therapeutic Agent with Problematic Properties.
Radeva L, Yoncheva K Pharmaceutics. 2025; 17(1).
PMID: 39861780 PMC: 11768323. DOI: 10.3390/pharmaceutics17010134.
Marine-Derived Polysaccharide Hydrogels as Delivery Platforms for Natural Bioactive Compounds.
Sepe F, Valentino A, Marcolongo L, Petillo O, Conte R, Margarucci S Int J Mol Sci. 2025; 26(2).
PMID: 39859476 PMC: 11766179. DOI: 10.3390/ijms26020764.
Niosome-loaded Tet-Amp against S. aureus, K. pneumoniae, and P. aeruginosa.
Bazargan E, Ashrafi F, Torbati E Braz J Microbiol. 2024; 55(4):3563-3589.
PMID: 39441517 PMC: 11711693. DOI: 10.1007/s42770-024-01516-6.
Paseban K, Noroozi S, Gharehcheloo R, Haddadian A, Falahi Robattorki F, Dibah H Heliyon. 2024; 10(16):e35651.
PMID: 39211930 PMC: 11357772. DOI: 10.1016/j.heliyon.2024.e35651.
Zaid Alkilani A, Sharaire Z, Hamed R, Basheer H ACS Omega. 2024; 9(31):33542-33556.
PMID: 39130600 PMC: 11307314. DOI: 10.1021/acsomega.4c01224.